{{Rsnum
|rsid=3731211
|Gene=CDKN2A
|Chromosome=9
|position=21986848
|Orientation=minus
|GMAF=0.264
|Gene_s=CDKN2A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 9.2 | 38.5 | 52.3
| HCB | 0.0 | 44.4 | 55.6
| JPT | 11.4 | 34.1 | 54.5
| YRI | 1.6 | 46.0 | 52.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 44.4 | 55.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22139419
|Trait=None
|Title=New gene functions in megakaryopoiesis and platelet formation.
|RiskAllele=A
|Pval=6E-14
|OR=3.2810
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=17459456
|Title=A common variant of the p16(INK4a) genetic region is associated with physical function in older people.
|OA=1
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=18761660
|Title=Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}